tiprankstipranks
Vivos Therapeutics reports Q1 EPS ($1.63), consensus ($1.17)
PremiumThe FlyVivos Therapeutics reports Q1 EPS ($1.63), consensus ($1.17)
2M ago
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
PremiumPress Releases
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
2M ago
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
PremiumPress Releases
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
2M ago
Vivos Therapeutics reports FY EPS ($11.14),  two estimates ($10.51)
PremiumThe FlyVivos Therapeutics reports FY EPS ($11.14), two estimates ($10.51)
3M ago
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
PremiumPress Releases
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
3M ago
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
PremiumPress Releases
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
3M ago
Vivos Therapeutics announces exercise of warrants for $4M in gross proceeds
PremiumThe FlyVivos Therapeutics announces exercise of warrants for $4M in gross proceeds
5M ago
Vivos Therapeutics highlights favorable market developments
PremiumThe Fly
Vivos Therapeutics highlights favorable market developments
5M ago
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
PremiumPress Releases
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100